Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1994-12-19
1996-04-30
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514169, 514182, A61K 3156
Patent
active
055125565
ABSTRACT:
The invention relates to a use of pregnane derivatives of the following general formula: ##STR1## in which R=H.sub.2, (H,OH), (H,OAcyl), or O, and especially the pregnane derivative(7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor -17-pregn-5(10)-en-20-yn-3-one (compound I), for the manufacture of a medicament for the prevention or treatment of tumors.
REFERENCES:
R. Smith et al., "Hormone Replacement Therapy: A Review", Journal of Drug Development, vol 4, No. 4, pp. 235-344, 1992.
L. Markiewicz et al., "In Vitro Evaluation of Estrogenic, Estrogen Antagonistic and Progestagenic Effects of a Steroidal Drug (Org OD-14) and its Metabolites on Human Endometrium" The Journal of Steroid Biochemistry vol. 35, No. 5, Apr. 1990, pp. 535-541.
Deckers Godefridus H. J.
Kloosterboer Helenius J.
Akzo Nobel N.V.
Goldberg Jerome D.
Gormley Mary E.
LandOfFree
Use of a pregnane derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of a pregnane derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a pregnane derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-628781